These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39145459)

  • 1. Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1.
    Beach C; MacLean D; Majorova D; Melemenidis S; Nambiar DK; Kim RK; Valbuena GN; Guglietta S; Krieg C; Darvish-Damavandi M; Suwa T; Easton A; Hillson LV; McCulloch AK; McMahon RK; Pennel K; Edwards J; O'Cathail SM; Roxburgh CS; Domingo E; Moon EJ; Jiang D; Jiang Y; Zhang Q; Koong AC; Woodruff TM; Graves EE; Maughan T; Buczacki SJ; Stucki M; Le QT; Leedham SJ; Giaccia AJ; Olcina MM
    J Clin Invest; 2024 Aug; 134(16):. PubMed ID: 39145459
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
    Laumonnier Y; Karsten CM; Köhl G; Köhl J
    Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
    Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
    FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen-Induced C5a/C5aR1 Axis Activation in Pulmonary CD11b
    Antoniou K; Ender F; Vollbrandt T; Laumonnier Y; Rathmann F; Pasare C; Singh H; Köhl J
    Cells; 2020 Jan; 9(2):. PubMed ID: 31991941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury.
    Peng Q; Wu W; Wu KY; Cao B; Qiang C; Li K; Sacks SH; Zhou W
    Kidney Int; 2019 Jul; 96(1):117-128. PubMed ID: 31029505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
    Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
    Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis.
    Sommerfeld O; Medyukhina A; Neugebauer S; Ghait M; Ulferts S; Lupp A; König R; Wetzker R; Schulz S; Figge MT; Bauer M; Press AT
    Mol Ther; 2021 Jan; 29(1):338-346. PubMed ID: 32966769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets.
    Nording H; Baron L; Haberthür D; Emschermann F; Mezger M; Sauter M; Sauter R; Patzelt J; Knoepp K; Nording A; Meusel M; Meyer-Saraei R; Hlushchuk R; Sedding D; Borst O; Eitel I; Karsten CM; Feil R; Pichler B; Erdmann J; Verschoor A; Chavakis E; Chavakis T; von Hundelshausen P; Köhl J; Gawaz M; Langer HF
    Nat Commun; 2021 Jun; 12(1):3352. PubMed ID: 34099640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.
    Zheng QY; Liang SJ; Xu F; Li GQ; Luo N; Wu S; Li Y; Tang M; Zhong Y; Chen J; Yang D; Sun DD; Zhang KQ; Xu GL
    Front Immunol; 2019; 10():1866. PubMed ID: 31447855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylatoxin Receptors C3aR and C5aR1 Are Important Factors That Influence the Impact of Ethanol on the Adipose Secretome.
    McCullough RL; McMullen MR; Poulsen KL; Kim A; Medof ME; Nagy LE
    Front Immunol; 2018; 9():2133. PubMed ID: 30294325
    [No Abstract]   [Full Text] [Related]  

  • 11. Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway.
    Bisht K; Canesin G; Cheytan T; Li M; Nemeth Z; Csizmadia E; Woodruff TM; Stec DE; Bulmer AC; Otterbein LE; Wegiel B
    J Immunol; 2019 May; 202(10):2982-2990. PubMed ID: 30952817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis.
    Dick J; Gan PY; Ford SL; Odobasic D; Alikhan MA; Loosen SH; Hall P; Westhorpe CL; Li A; Ooi JD; Woodruff TM; Mackay CR; Kitching AR; Hickey MJ; Holdsworth SR
    Kidney Int; 2018 Mar; 93(3):615-625. PubMed ID: 29241626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of anaphylatoxin C5a on antigen presenting cells, roles for C5aR1 and C5aR2.
    Zaal A; van Ham SM; Ten Brinke A
    Immunol Lett; 2019 May; 209():45-52. PubMed ID: 30959077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
    Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C5aR1 regulates T follicular helper differentiation and chronic graft-versus-host disease bronchiolitis obliterans.
    Verghese DA; Chun N; Paz K; Fribourg M; Woodruff TM; Flynn R; Hu Y; Xiong H; Zhang W; Yi Z; Du J; Blazar BR; Heeger PS
    JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta.
    Hernandez MX; Namiranian P; Nguyen E; Fonseca MI; Tenner AJ
    ASN Neuro; 2017 Feb; 9(1):1759091416687871. PubMed ID: 28078911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1.
    Pandey S; Li XX; Srivastava A; Baidya M; Kumari P; Dwivedi H; Chaturvedi M; Ghosh E; Woodruff TM; Shukla AK
    J Biol Chem; 2019 Jun; 294(24):9416-9429. PubMed ID: 31036565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.
    Gorman DM; Li XX; Lee JD; Fung JN; Cui CS; Lee HS; Rolfe BE; Woodruff TM; Clark RJ
    J Med Chem; 2021 Nov; 64(22):16598-16608. PubMed ID: 34762432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics.
    Woodruff TM; Shukla AK
    Trends Immunol; 2020 Nov; 41(11):965-967. PubMed ID: 33023856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
    Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
    MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.